1. Home
  2. SAGE vs KTF Comparison

SAGE vs KTF Comparison

Compare SAGE & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • KTF
  • Stock Information
  • Founded
  • SAGE 2010
  • KTF 1988
  • Country
  • SAGE United States
  • KTF United States
  • Employees
  • SAGE N/A
  • KTF N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • KTF Finance Companies
  • Sector
  • SAGE Health Care
  • KTF Finance
  • Exchange
  • SAGE Nasdaq
  • KTF Nasdaq
  • Market Cap
  • SAGE 415.0M
  • KTF 350.7M
  • IPO Year
  • SAGE 2014
  • KTF N/A
  • Fundamental
  • Price
  • SAGE $7.79
  • KTF $9.01
  • Analyst Decision
  • SAGE Hold
  • KTF
  • Analyst Count
  • SAGE 19
  • KTF 0
  • Target Price
  • SAGE $9.88
  • KTF N/A
  • AVG Volume (30 Days)
  • SAGE 1.2M
  • KTF 103.3K
  • Earning Date
  • SAGE 04-29-2025
  • KTF 01-01-0001
  • Dividend Yield
  • SAGE N/A
  • KTF 3.54%
  • EPS Growth
  • SAGE N/A
  • KTF N/A
  • EPS
  • SAGE N/A
  • KTF 0.39
  • Revenue
  • SAGE $41,243,000.00
  • KTF N/A
  • Revenue This Year
  • SAGE $100.64
  • KTF N/A
  • Revenue Next Year
  • SAGE $70.19
  • KTF N/A
  • P/E Ratio
  • SAGE N/A
  • KTF $23.10
  • Revenue Growth
  • SAGE N/A
  • KTF N/A
  • 52 Week Low
  • SAGE $4.62
  • KTF $7.40
  • 52 Week High
  • SAGE $14.97
  • KTF $9.12
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 56.30
  • KTF 43.06
  • Support Level
  • SAGE $7.56
  • KTF $8.76
  • Resistance Level
  • SAGE $7.89
  • KTF $9.03
  • Average True Range (ATR)
  • SAGE 0.36
  • KTF 0.13
  • MACD
  • SAGE 0.06
  • KTF 0.01
  • Stochastic Oscillator
  • SAGE 88.03
  • KTF 38.24

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About KTF DWS Municipal Income Trust

DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.

Share on Social Networks: